Cardiva Vascade 6/7f Vcs
Payments companies reported to CMS as associated with Cardiva Vascade 6/7f Vcs. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cardiva Vascade 6/7f Vcs, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cardiva Vascade 6/7f Vcs
These are the largest totals companies reported as associated with Cardiva Vascade 6/7f Vcs. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Nouri Al Khaled | Evergreen Park, IL | Cardiovascular Disease | $51,562.51 |
| David Delurgio | Atlanta, GA | Clinical Cardiac Electrophysiology | $18,887.00 |
| Matthew Recht | Cincinnati, OH | Vascular Surgery | $10,974.66 |
| Craig Walker | Houma, LA | Interventional Cardiology | $10,327.55 |
| Bryan Cotton | Nashville, TN | Trauma Surgery | $9,861.65 |
| Hugh Mcelderry | Birmingham, AL | Clinical Cardiac Electrophysiology | $8,684.91 |
| Dieter Adelmann | San Francisco, CA | Anesthesiology | $8,241.15 |
| Patrick Muck | Cincinnati, OH | Vascular Surgery | $6,776.99 |
| Ravi Veeraswamy | Charleston, SC | Vascular Surgery | $6,013.68 |
| Ruby Satpathy | Jacksonville, FL | Interventional Cardiology | $5,287.26 |
Prescribed Cardiva Vascade 6/7f Vcs?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.